13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001596452
Total reported value
$131.7M
$131.7M
35 檔
56.4%
As reported in its official Q3 2024 Form 13F filing, Sivik Global Healthcare LLC's tracked investment portfolio stood at $131.7M with 35 total positions.
In Q3 2024, Sivik Global Healthcare LLC adopted a defensive or profit-taking posture, trimming 13 positions and completely liquidating 12 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 12.55% | — | — | |
| 2 | LLY | Eli Lilly & Co | Stock-Healthcare | 5.44% | — | -3.33% | |
| 3 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.57% | — | -7.14% | |
| 4 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 4.54% | — | — | |
| 5 | UHS | Universal Health Services-b | Stock-Healthcare | 4.36% | — | +12.50% | |
| 6 | MCK | Mckesson CORP | Stock-Healthcare | 4.19% | — | +11.11% | |
| 7 | SYK | Stryker CORP | Stock-Healthcare | 4.13% | — | +8.00% | |
| 8 | BSX | Boston Scientific CORP | Stock-Healthcare | 3.73% | — | -8.70% | |
| 9 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.64% | — | — | |
| 10 | DHR | Danaher CORP | Stock-Healthcare | 3.53% | — | — | |
| 11 | HCA | Hca Healthcare Inc | Stock-Healthcare | 3.44% | — | -20.00% | |
| 12 | SGRY | Surgery Partners Inc | Stock-Other | 3.14% | — | -8.00% | |
| 13 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 3.09% | — | +43.74% | |
| 14 | ABT | Abbott Laboratories | Stock-Healthcare | 2.90% | — | — | |
| 15 | AVTR | Avantor Inc | Stock-Healthcare | 2.74% | — | — | |
| 16 | BDX | Becton Dickinson And Co | Stock-Healthcare | 2.55% | — | — | |
| 17 | BAX | Baxter International Inc | Stock-Healthcare | 2.41% | — | +50.00% | |
| 18 | COR | Cencora Inc | Stock-Healthcare | 2.38% | — | -3.85% | |
| 19 | MDT | Medtronic plc | Stock-Healthcare | 2.29% | — | — | |
| 20 | RVTY | Revvity Inc | Stock-Healthcare | 2.16% | — | — | |
| 21 | WST | West Pharmaceutical Services | Stock-Healthcare | 2.16% | — | +30.77% | |
| 22 | CAH | Cardinal Health Inc | Stock-Healthcare | 2.11% | — | -25.00% | |
| 23 | SEM | Select Medical Holdings CORP | Stock-Other | 2.07% | — | -3.45% | |
| 24 | EHC | Encompass Health CORP | Stock-Healthcare | 2.05% | — | -9.09% | |
| 25 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.97% | — | -33.33% | |
| 26 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 1.85% | — | -6.67% | |
| 27 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 1.83% | — | — | |
| 28 | RGEN | Repligen CORP | Stock-Healthcare | 1.58% | — | +66.67% | |
| 29 | MRVI | Maravai Lifesciences Hldgs-a | Stock-Other | 1.50% | — | -5.56% | |
| 30 | HUM | Humana Inc | Stock-Healthcare | 1.34% | — | +33.33% | |
| 31 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 1.30% | — | -15.00% | |
| 32 | STVN | Stevanato Group S.p.A. | Stock-Other | 1.19% | — | — | |
| 33 | ASND | Ascendis Pharma A/S | Stock-Other | 0.63% | — | — | |
| 34 | ✓ | Put - Spy 100 @ 565 Exp 10/31/2024 | Stock-Other | 0.36% | — | — | |
| 35 | ✓ | Put - Spy 100 @ 553 Exp 10/31/2024 | Stock-Other | 0.32% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +12.6% | NEW | New buy |
| 2 | ABT | Abbott Laboratories | +2.9% | NEW | New buy |
| 3 | MDT | Medtronic plc | +2.3% | NEW | New buy |
| 4 | RVTY | Revvity Inc | +2.2% | NEW | New buy |
| 5 | ZBH | Zimmer Biomet Holdings Inc | +1.8% | NEW | New buy |
| 6 | UHS | Universal Health Services-b | +1.7% | +12.50% | Add |
| 7 | THC | Tenet Healthcare CORP | +1.2% | -7.14% | Trim |
| 8 | BAX | Baxter International Inc | +1.2% | +50.00% | Add |
| 9 | STVN | Stevanato Group S.p.A. | +1.2% | NEW | New buy |
| 10 | ACHC | Acadia Healthcare Co Inc | +1.2% | +43.74% | Add |
| 11 | SYK | Stryker CORP | +1.1% | +8.00% | Add |
| 12 | SGRY | Surgery Partners Inc | +1% | -8.00% | Trim |
| 13 | RGEN | Repligen CORP | +0.9% | +66.67% | Add |
| 14 | AVTR | Avantor Inc | +0.8% | — | Unchanged |
| 15 | DHR | Danaher CORP | +0.8% | — | Unchanged |
| 16 | ISRG | Intuitive Surgical Inc | +0.8% | — | Unchanged |
| 17 | ASND | Ascendis Pharma A/S | +0.6% | NEW | New buy |
| 18 | WST | West Pharmaceutical Services | +0.6% | +30.77% | Add |
| 19 | LLY | Eli Lilly & Co | +0.6% | -3.33% | Trim |
| 20 | HCA | Hca Healthcare Inc | +0.6% | -20.00% | Trim |
| 21 | BSX | Boston Scientific CORP | +0.6% | -8.70% | Trim |
| 22 | SNN | Smith & Nephew PLC -spon Adr | +0.5% | -6.67% | Trim |
| 23 | BDX | Becton Dickinson And Co | +0.5% | — | Unchanged |
| 24 | MCK | Mckesson CORP | +0.4% | +11.11% | Add |
| 25 | ✓ | Put - Spy 100 @ 565 Exp 10/31/2024 | +0.4% | NEW | New buy |
| 26 | EHC | Encompass Health CORP | +0.4% | -9.09% | Trim |
| 27 | MRVI | Maravai Lifesciences Hldgs-a | +0.3% | -5.56% | Trim |
| 28 | HUM | Humana Inc | +0.3% | +33.33% | Add |
| 29 | ✓ | Put - Spy 100 @ 553 Exp 10/31/2024 | +0.3% | NEW | New buy |
| 30 | COR | Cencora Inc | +0.3% | -3.85% | Trim |
| 31 | SEM | Select Medical Holdings CORP | +0.2% | -3.45% | Trim |
| 32 | TEVA | Teva Pharmaceutical-sp Adr | +0.1% | -15.00% | Trim |
| 33 | CAH | Cardinal Health Inc | 0% | -25.00% | Trim |
| 34 | NVO | Novo-nordisk A/s-spons Adr | -0.1% | — | Unchanged |
| 35 | VRTX | Vertex Pharmaceuticals Inc | -0.6% | -33.33% | Trim |
| 36 | BRKR | Bruker CORP | -0.9% | EXIT | Sold out |
| 37 | MEDP | Medpace Holdings Inc | -1.1% | EXIT | Sold out |
| 38 | NTRA | Natera Inc | -1.2% | EXIT | Sold out |
| 39 | DXCM | Dexcom Inc | -1.2% | EXIT | Sold out |
| 40 | A | Agilent Technologies Inc | -1.6% | EXIT | Sold out |
| 41 | PODD | Insulet CORP | -1.8% | EXIT | Sold out |
| 42 | EW | Edwards Lifesciences CORP | -2% | EXIT | Sold out |
| 43 | RMD | Resmed Inc | -2.1% | EXIT | Sold out |
| 44 | BIIB | Biogen Inc | -2.5% | EXIT | Sold out |
| 45 | TMO | Thermo Fisher Scientific Inc | -2.8% | EXIT | Sold out |
| 46 | MRK | Merck & Co. Inc. | -2.9% | EXIT | Sold out |
| 47 | ✓ | Put - Spy 100 @ 545 Exp 07/19/2024 | -19.6% | EXIT | Sold out |
According to official SEC Form 13F filings, Sivik Global Healthcare LLC reported a total U.S. public equity portfolio value of $131.7M across 35 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including XBI, LLY, THC) accounted for 56.4% of total reported equity market value during Q3 2024.
Top New Position Initiated
XBI
市值: $29.6M
Top Position Liquidated / Trimmed
PUT - SPY 100 @ 545 EXP 07/19/2024
前期市值: $54.5M
During Q3 2024, Sivik Global Healthcare LLC's top holdings by market value included XBI (12.6%)、LLY (5.4%)、THC (4.6%). The largest single position, XBI, represented 12.6% of total portfolio value.
In Q3 2024, Sivik Global Healthcare LLC made 42 total portfolio adjustments, initiating 9 new buys, adding to 8 positions, trimming 13 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.